Group 1 - The phenomenon known as "post-holiday syndrome" is observed as individuals return to work after the Spring Festival, indicating a need to readjust to work rhythms after a break [1] - Recommendations for physical adjustment include gradually shifting sleep schedules, maintaining a balanced diet rich in vegetables and proteins, and engaging in light exercises to improve mood and energy levels [1][2] - Mental adjustment strategies involve accepting feelings of reluctance to return to work, creating task lists to establish a sense of control, and utilizing techniques like the Pomodoro Technique to maintain focus [2] Group 2 - The return travel period poses a high risk for respiratory infections due to crowded and enclosed spaces, with recommendations for health self-assessment and preventive measures such as mask-wearing and hand hygiene [3] - JD Internet Hospital offers 24/7 online consultation services, providing timely medical responses and access to expert advice through its app, enhancing healthcare accessibility for users during the post-holiday period [5] - The integration of AI technology in healthcare services, such as the "JD Medical Inquiry" model, allows for comprehensive patient support and evidence-based recommendations, improving the quality of healthcare delivery [5]

平安健康医疗科技有限公司是一家通过移动平台和线下资源从事提供医疗及健康服务的公司。该公司通 过两个分部开展其业务。医疗服务分部主要从事在线咨询、转诊及预约挂号、住院安排、疾病诊疗及相 关药品、医疗器械销售。健康服务分部提供多种整合医疗健康机构服务的标准化健康服务包，以满足用 户健康相关需要，覆盖体检、养老、齿科、抗衰、泛健康等多品类及服务形态。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月23日南向资金增持69.2万股平安好医生（01833.HK）。近5个交易日中，获南向资金 增持的有4天，累计净增持674.9万股。近20个交易日中，获南向资金增持的有12天，累计净增持505.2万 股。截至目前，南向资金持有平安好医生（01833.HK）4.85亿股，占公司已发行普通股的22.45%。 ...

为确保我省群众度过一个安心祥和的健康年，我省首批获准开通的互联网医院之一"山西医科大学第一 医院互联网医院"春节线上服务"不打烊"，为公众健康提供温情陪伴。 春节期间，山医大一院互联网医院可以在线上进行常见病慢病复诊、报告解读等，有就诊需求的患者只 需通过手机，即可与专家"屏对屏"交流，省去奔波排队的时间，把精力留给最珍贵的团圆。同时，互联 网医院的"AI智能导诊"功能24小时在线，提供智能分诊导诊服务。患者只需在互联网医院的手机应用中 打开"智能分诊"模块，简单描述症状后，便可得到AI机器人推荐的科室选项，预约挂号。此外，还可以 使用"智能预问诊"功能，根据AI模拟医生的问诊思路，提前系统梳理病情，提高面诊效率。春节期间， 互联网医院仍可绑定父母、子女信息，可办理代预约复诊、线上开方，代缴纳药品、检查费用，代办理 住院登记、预约金充值，代查询检查报告等业务。（魏 薇） ...

Core Viewpoint - JD Health (06618.HK) announced that it will hold a board meeting on March 5, 2026, to approve the annual performance for the year ending December 31, 2025, and to consider the proposal for the final dividend payment, if any [1] Group 1 - The board meeting is scheduled for March 5, 2026 [1] - The meeting will focus on approving the annual performance of the company and its subsidiaries for the year ending December 31, 2025 [1] - The board will also consider the proposal for the final dividend payment [1]

春节假期过后，港股今日迎来马年首个交易日，恒指、恒科指数低开。截至收盘，恒指早盘收跌 0.61%，科指早盘收跌2.28%，恒指大市成交额917.55亿港元。盘面上，石油、人工智能、机器人概念股 逆势走强，影视娱乐、互联网医疗、线上零售及明星科网股走势疲弱。个股方面，智谱(02513.HK)大涨 19.09%，MINIMAX-WP(00100.HK)涨10.04%，中国石油股份(00857.HK)涨4.58%，百度(09888.HK)跌 5.67%，阿里巴巴(09988.HK)跌3.75%，哔哩哔哩(09626.HK)跌5.12%。 来源：滚动播报 ...

来源：新浪港股 此外，在商品方面，集团进一步强化供应链服务能力，并持续优化产品销售组合，提升高毛利品类占 比，从而显著改善整体经营效率与盈利能力。 综合多方有利因素，集团亦预期于2025财年取得经调整净利润不少于约人民币500万元，相较2024财年 约人民币5720万元 的经调整净亏损，实现扭亏为盈的转折。 叮当健康（09886）公布，预期2025财年净亏损将较2024财年取得的约人民币3.8亿元净亏损显著收窄逾 80%。此项改善主要归因于以下因素：首先，2024财年计提商誉减值亏损约人民币1.989亿元及其他无 形资产减值亏损约人民币680万元，预期2025财年相关减值金额将显著减少。其次，集团持续优化城市 布局策略，聚焦并深耕以北京、上海、深圳为代表的核心一线城市，积极拓展并加密当地智慧药房网 络，有效推动营运效率，带动整体业务实现稳健增长。 ...

作为一款免费的健康管理类App，蚂蚁阿福与多地卫健委、医保局合作，连接全国5000家医院及30万名 真人医生，提供从健康问答到数字就医的全链路服务。 今年是"健康中国"战略新十年的伊始，用科技武装自己和家人的健康，正在成为新趋势。除夕当天，蚂 蚁阿福也宣布，其"健康福"红包将发放至大年初七，新注册阿福App的用户可获得16.8元支付宝红包， 寓意新一年健康有福气。 2月10日，蚂蚁阿福官宣成为央视CCTV健康生活合作伙伴，随即在除夕夜亮相央视春晚舞台。 这个春节，返乡青年教家人用阿福管理健康成为新趋势，拉动蚂蚁阿福App下载量持续提升，推动其在 除夕前，连续三天登顶App Store应用下载总榜第一。 "健康是福，健康的事问问阿福"，2月16日的马年央视春晚舞台上，"蚂蚁阿福"出现在小品《血压计》 中，成为又一个登上春晚舞台的科技品牌。 ...

除夕夜20:00，央视2026年春节联欢晚会如约而至。在小品《血压计》表演时，不少观众注意到，剧中 那位给老人看体检报告的医生叫"阿福"，而他诊所里印着一行大字："健康是福，健康的事问问阿福。" 而就在一周前，蚂蚁阿福刚刚官宣成为央视CCTV健康生活合作伙伴。 这是蚂蚁集团旗下健康应用"蚂蚁阿福"在春晚上的亮相。这个巧妙的植入，不仅自然贴合春晚全家欢的 调性，也通过温情叙事，让亿万观众在除夕夜这个合家团圆的夜晚，记住了"蚂蚁阿福"的品牌和价值主 张。 埃森哲的调研数据显示，相比2021年，2025年中国消费者对健康的重视度从78%上升到了87%，已经成 为中国消费者最重视的事项。在这一趋势下，随着春节返乡高峰的到来，蚂蚁阿福这款应用的热度也持 续攀升。 媒体报道显示，许多年轻人回老家后在为父母准备红包、年货的同时，也会给父母手机里装上阿福 App，希望在自己没法陪伴父母的时候，通过阿福远程关注父母的健康，父母有些头疼脑热也可以先咨 询阿福获得专业建议。 为了让中老年人使用更简单，阿福在春节前上线了"长辈模式"——大字体、默认语音播报、听得懂方 言，还能打电话咨询。这一波返乡教家人用阿福的热潮，直接带飞阿福Ap ...

Group 1 - The mainland internet healthcare sector is entering a new phase driven by tech giants accelerating AI innovation and government policy support, such as the online initial diagnosis pilot program launched in Beijing [1] - Despite challenges in profitability, leading companies are leveraging AI ecosystems and innovative strategies for long-term sustainable growth [1] Group 2 - The company maintains a "Buy" rating for Alibaba Health (00241) with a target price of HKD 7.8, expecting a compound annual growth rate (CAGR) of 13% in revenue and 24% in adjusted net profit from FY2026 to FY2028, driven by growth in innovative drugs and healthcare products, deepening synergy with Alibaba Group (09988), and increasing AI application [1] - The company also favors Ping An Good Doctor (01833) with a "Buy" rating and a target price of HKD 20, anticipating a CAGR of 16% in revenue and 56% in adjusted net profit from FY2025 to FY2027, supported by deepening synergy with Ping An Insurance (02318) and ongoing AI empowerment [1] Group 3 - The company maintains an "Overweight" rating for the mainland healthcare sector, preferring leading innovative pharmaceutical companies and contract research, development, and manufacturing organizations (CRDMOs) [2] - The company is optimistic about internet healthcare firms that effectively utilize real-world data to optimize AI algorithms and enhance service quality [2] - Preferred stocks include BeiGene (06160), Innovent Biologics (01801), Hansoh Pharmaceutical (03692), China Biologic Products (01177), Hutchison China MediTech (00013), WuXi Biologics (02269), WuXi AppTec (02359), and Alibaba Health [2]

Group 1 - The mainland internet healthcare sector is entering a new phase driven by tech giants accelerating AI innovation and government policy support, such as the online initial diagnosis pilot program launched in Beijing [1] - Despite challenges in profitability, leading companies are leveraging AI ecosystems and innovative strategies for long-term sustainable growth [1] - Alibaba Health (00241) is favored with a "Buy" rating and a target price of HKD 7.8, with expected revenue and adjusted net profit CAGR of 13% and 24% from FY2026 to FY2028, driven by innovative drugs, healthcare product growth, and deepening synergies with Alibaba [1] Group 2 - Ping An Good Doctor (01833) is also favored with a "Buy" rating and a target price of HKD 20, with expected revenue and adjusted net profit CAGR of 16% and 56% from FY2025 to FY2027, supported by synergies with Ping An (02318) and ongoing AI empowerment [1] - The firm maintains an "Overweight" rating on the mainland healthcare sector, preferring leading innovative pharmaceutical companies and contract research, development, and manufacturing organizations (CRDMOs) [2] - Companies that effectively utilize real-world data to optimize AI algorithms and enhance service quality in internet healthcare are also favored, with preferred stocks including BeiGene (06160), Innovent Biologics (01801), Hansoh Pharmaceutical (03692), China Biologic Products (01177), Hutchison China MediTech (00013), WuXi Biologics (02269), WuXi AppTec (02359), and Alibaba Health [2]